Tevogen Bio Holdings(TVGN)
$6.22+0.22 (+3.67%)
TVGN
Tevogen Bio Holdings financials statements
$6.22
At close:+0.22 (+3.67%)
Want to see TVGN full AI Analyst Report?
Tevogen Bio Holdings (TVGN) Ratios
323 Followers
Tevogen Bio Holdings Ratios
TVGN's free cash flow for Q2 2026 was $-3.01M. For the 2026 fiscal year, TVGN's free cash flow was increased by $3.00 and operating cash flow was $-3.01M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
| Quick Ratio | 0.22 | 0.26 | 0.02 | 2.98 | 10.74 |
| Cash Ratio | 0.08 | 0.14 | 0.01 | 2.80 | 10.66 |
| Solvency Ratio | -2.04 | -0.96 | -0.60 | 0.11 | -0.65 |
| Operating Cash Flow Ratio | -1.74 | -1.33 | -0.10 | -4.42 | -7.90 |
| Short-Term Operating Cash Flow Coverage | -6.23 | -7.27 | -0.10 | 0.00 | 0.00 |
| Net Current Asset Value | $ -11.08M | $ -7.77M | $ -98.21M | $ -35.85M | $ -16.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.71 | 0.83 | 17.33 | 5.17 | 3.07 |
| Debt-to-Equity Ratio | -0.38 | -0.43 | -1.01 | -1.18 | -1.42 |
| Debt-to-Capital Ratio | -0.60 | -0.76 | 96.32 | 6.61 | 3.36 |
| Long-Term Debt-to-Capital Ratio | -0.16 | -0.18 | -0.18 | 7.35 | 3.36 |
| Financial Leverage Ratio | -0.53 | -0.52 | -0.06 | -0.23 | -0.46 |
| Debt Service Coverage Ratio | -11.76 | -7.16 | -0.73 | 0.00 | -25.04 |
| Interest Coverage Ratio | -133.63 | -291.05 | -34.54 | 0.00 | -7.72 |
| Debt to Market Cap | 0.06 | 0.02 | 0.05 | 0.03 | 0.05 |
| Interest Debt Per Share | 0.99 | 1.05 | 0.58 | 0.33 | 0.50 |
| Net Debt to EBITDA | -0.10 | -0.12 | -1.60 | 7.83 | -1.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 73.68% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.52% | 25.63% | 683.90% | -462.54% | 337.71% |
| Return on Assets (ROA) | -599.49% | -292.18% | -1098.50% | 56.96% | -203.66% |
| Return on Equity (ROE) | 319.08% | 151.55% | 64.05% | -12.98% | 94.59% |
| Return on Capital Employed (ROCE) | 973.40% | 959.76% | 11.06% | -16.49% | -66.07% |
| Return on Invested Capital (ROIC) | 3698.66% | 1447.31% | -892.63% | -15.74% | -66.07% |
| Return on Tangible Assets | -599.49% | -292.18% | -1098.50% | 56.96% | -203.66% |
| Earnings Yield | -47.79% | -6.70% | -3.29% | 0.36% | -3.27% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.08 | 0.11 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -4703.12 | -3297.70 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 4703.12 | 3297.70 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -3.71 | -4.09 | -0.05 | -0.07 | -0.11 |
| Free Cash Flow Per Share | -3.73 | -4.09 | -0.05 | -0.08 | -0.11 |
| Dividend Paid and CapEx Coverage Ratio | -191.32 | 0.00 | -61.44 | -18.07 | -48.07 |
| Capital Expenditure Coverage Ratio | -191.32 | 0.00 | -61.44 | -18.07 | -48.07 |
| Operating Cash Flow Coverage Ratio | -3.98 | -4.16 | -0.09 | -0.22 | -0.22 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -22.54% | -7.94% | -0.45% | -0.74% | -1.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.05 | -11.00 | -30.42 | 281.19 | -30.55 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -6.68 | -22.64 | -19.48 | -36.51 | -28.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.44 | -12.59 | -221.51 | -135.70 | -88.48 |
| Price-to-Operating Cash Flow Ratio | -4.46 | -12.59 | -225.12 | -143.21 | -90.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.03 | -0.00 | 0.30 | -2.53 | 0.00 |
| Enterprise Value Multiple | -2.25 | -11.62 | -32.84 | 289.02 | -32.88 |
| Enterprise Value | 57.53M | 152.68M | 1.93B | 1.27B | 492.82M |
| EV to EBITDA | -2.25 | -11.62 | -32.84 | 289.02 | -32.88 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -4.64 | -12.72 | -232.88 | -139.48 | -91.52 |
| EV to Operating Cash Flow | -4.67 | -12.72 | -236.67 | -147.20 | -93.43 |
| Tangible Book Value Per Share | -2.48 | -2.28 | -0.57 | -0.28 | -0.34 |
| Shareholders’ Equity Per Share | -2.48 | -2.28 | -0.57 | -0.28 | -0.34 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -7.91 | -3.45 | -0.37 | 0.04 | -0.33 |
| Tax Burden | 1.00 | 0.74 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.01 | 1.01 | 1.02 | 1.00 | 1.04 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.47 | 0.87 | 0.14 | 0.39 | 0.34 |
Currency in USD

